Stephen Chun: Long-term outcomes of IMRT for locally-advanced lung cancer
Stephen Chun made the following post on X:
“Happy to report long-term outcomes of intensity modulated radiotherapy for locally-advanced lung cancer in JAMA Oncology. May this finally put an end to the debate on IMRT for NSCLC.”
Eric K. Singhi retweeted the post, added the following:
“Does IMRT improve outcomes v 3D-CRT for unresectable NSCLC?
- IMRT: 2x less severe pneumonitis, decrease cardiac exposure
- Lung V5 radiation no effect on survival/severe AEs
- <20% heart exposure to 40 Gy increase survival
Supports IMRT over 3D-CRT.”
Source: Stephen Chun/X and Eric K. Singhi/X
Dr. Eric K. Singhi is a thoracic and head and neck medical oncologist, currently serving as an Assistant Professor in the Department of General Oncology within the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston, TX.
Dr. Singhi is highly skilled in general internal medicine and hematology/oncology, with a special focus on thoracic medical oncology. Dr. Eric K. Singhi is committed to delivering exceptional care to his patients and advancing the field of oncology..
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023